Ubrelvy 100 mg tablets contain ubrogepant, a CGRP receptor antagonist prescribed for the acute treatment of migraine attacks with or without aura in adults. It is not used to prevent migraine.

Active ingredient / formula: Each tablet contains ubrogepant 100 mg.

How to use: Take exactly as prescribed. The usual adult dose is 50 mg or 100 mg by mouth when a migraine starts. If needed, a second dose may be taken at least 2 hours after the first dose. Do not exceed 200 mg in 24 hours. Your doctor may set a lower limit if you take certain medicines or have liver/kidney problems.

Warnings: Tell your doctor about all medicines, especially strong CYP3A4 inhibitors such as ketoconazole, clarithromycin, or itraconazole, because they may make Ubrelvy unsafe. Ask before use during pregnancy or breastfeeding, or with severe liver/kidney disease. Seek urgent help for allergic swelling, rash, or trouble breathing. This information does not replace the approved leaflet or medical advice.